시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
의약품 및 바이오테크놀러지 모듈식 제조 시설 시장 : 시설 사이즈와 목적별, 운영 규모별, 대상 산업 유형별, 사용 재료별, 주요 지역별 - 업계 동향과 세계 예측(2023-2035년)
Modular Construction Market in Pharmaceutical & Biotechnology-Distribution by Size & Purposeof Facility, Scale of Operation, Type of Industry Served, Material Used & Key Geographical Regions: Industry Trends & Global Forecasts, 2023-2035
상품코드 : 1215500
리서치사 : Roots Analysis
발행일 : 2023년 08월
페이지 정보 : 영문 387 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,799 ￦ 6,609,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,999 ￦ 9,639,000
PDF (One-Location Site License) help
PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,599 ￦ 14,596,000
PDF (Department License) help
PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 17,999 ￦ 24,788,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 의약품 및 바이오테크놀러지 모듈식 제조 시설 시장에 대해 조사했으며, 시장 개요, 시설 규모 및 목적별/운영 규모별/대상 산업 유형별/사용 재료별/주요 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

제2장 주요 요약

제3장 서론

제4장 시장 구도 : 모듈식 시설 제조업체

제5장 시장 구도 : 모듈식 클린룸 프로바이더

제6장 모듈 설비 제조업체 : 기업 경쟁력 분석

제7장 기업 개요

제8장 파트너십과 협업

제9장 의약품 및 바이오테크놀러지 모듈식 프로젝트 사례 연구

제10장 의약품 업계 시설 건설 동향

제11장 비용과 시간 최적화 프레임워크

제12장 시장 예측

제13장 보급 및 신흥 동향

제14장 향후 성장 기회

제15장 결론

제16장 주요 인사이트

제17장 부록 I : 표 형식 데이터

제18장 부록 II : 기업 및 조직 리스트

LSH
영문 목차

영문목차

INTRODUCTION

In the past few years, modular facilities or prefabricated buildings have emerged as a promising alternative to the conventionally built pharma / biotech manufacturing facilities. Modular construction involves building of structures using prefabricated modular units, off-site, under controlled factory setting; these modular units are later assembled on site. It is interesting to note that off-site construction can eliminate 60%-90% of the weather-related project concerns. Further, modular facilities can be built 40% faster as compared to a conventional construction, which could take up to three years. Therefore, considering the various advantages offered by this approach, several pharmaceutical players are now shifting their focus from conventional plants to modular facilities. Specifically, modular facility providers are catering to the needs of various players engaged in the development of therapeutics, including cell and gene therapy, biosimilars and vaccines. To provide more context, modular biomanufacturing includes division of individual production processes, such as fermentation, purification and formulation, into separate modules that can be easily assembled and disassembled, allowing for flexibility and scalability. In addition, modular manufacturing allows the use of smaller-scale production units, which can be more flexible and responsive to dynamic market demands. Moreover, temporary modular buildings can be relocated after installation, based on needs of the end-user. However, mass production, complex decision-making, construction approvals and early financing can hinder the adoption of modular constructs. If healthcare stakeholders are able to overcome these challenges, modular construction can serve as a lucrative approach that provides greater flexibility and enables faster time-to-market for new products.

SCOPE OF THE REPORT

"The Modular Facilities in Pharmaceutical and Biotechnology Market (3rd Edition), 2023-2035, Distribution by Size of Facility (Small, Mid-sized, Large and Very Large), Type of Industry Served (Pharmaceutical and Biotechnology), Type of Modular Construct (Hybrid Skid Modular Constructs, Skid-Mounted Modular Constructs, Plug-and-Play Modular Constructs, Truckable Modular Constructs and Other Modular Constructs), Type of Construction Component (Process Equipment, Base Building, Mechanical, Electrical and Plumbing System, Process Commodities and Other Construction Components), Purpose of Facility (Manufacturing Facilities, Aseptic Filling Facilities, Research and Development Facilities and Other Facilities), Scale of Operation (Clinical and Commercial), Type of Product (Cell and Gene Therapies, Vaccines, Biosimilars, Monoclonal Antibodies, Advanced Pharmaceuticals, Sterile Products, Viral Vectors and Other Products), Type of Expansion (New Facilities, Facility Expansions and Planned Expansions), Type of Modular Construction (Relocatable Modular Construction, Permanent Modular Construction), Type of Material Used (Steel, Wood and Concrete) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035" report features an extensive study of the current market landscape and future opportunity, offering an informed opinion on the likely adoption of modular facilities in the pharmaceutical and biotechnology industries, over the next 12 years. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. The report answers the following key questions related to this domain.

Key Advantages Offered by Modular Facilities

Modular facilities have emerged as a promising alternative to conventional facilities owing to the multiple benefits that they offer. For instance, modular facilities can help in achieving 25%-30% reduction in the overall cost of construction, minimal plant site interruption, 50%-60% faster construction timelines, as well as ensure portability, safe working conditions and sustainability. In addition, better quality of products can be achieved by modular construction approaches owing to the fact that modules are built in a controlled factory setting. In addition, these modules are inspected more thoroughly and frequently before they are shipped to the construction site meeting desired quality standards. Moreover, modular construction allows more flexibility in terms of design, as a higher number of materials and finishes can be used, as compared to conventional facilities.

Current Market Landscape of Modular Facilities

The modular facilities market landscape features an extensive list of over 50 large, mid-sized, small and very small players. It is worth highlighting that more than 250 players are engaged in offering modular cleanrooms, along with various cleanroom accessories and customization options, in order to make them suitable for application in the life sciences industry. It is expected that modular facilities will become more streamlined and standardized in the future, serving as an efficient cost saving solution. Additionally, modular techniques allow building of smaller and specialized processing plants whenever rapid deployment of a therapy becomes critical in both developed and developing countries. Further, many, if not most, expansions and new facilities in the pharmaceutical and biotechnology industry are likely to be modular constructions in the near future.

Key Drivers in the Modular Facilities Market

Over the past few years, several factors have contributed to reform the facility construction paradigm within the pharmaceutical and biotechnology industries. The increasing preference and demand for personalized therapies and novel therapeutic interventions intended for the treatment of various ailments has compelled pharmaceutical companies to look beyond the traditional manufacturing and expansion practices. Lack of adequate manufacturing infrastructure, increased cost of construction and delay in project deliveries has collectively contributed to the emergence of off-site construction models.

Overall Size of Modular Facilities Market

Driven by the rising interest of stakeholders towards improvement of manufacturing and production efficiency, the anticipated lucrative opportunities and growth associated with adoption of modular facilities, this market is expected to witness noteworthy growth in the foreseen future. Specifically, in terms of type of product, the market is anticipated to be driven by manufacturing units for cell and gene therapies, as well as vaccines and biosimilars. In addition, presently, close to 70% of the market share is captured by players based in North America and Europe. However, in the long run, markets in emerging regions, such as countries based in Asia, MENA and rest of the world are anticipated to grow at a faster pace.

Example Players in the Modular Facilities Market

Examples of players engaged in this domain (which have also been profiled in this report) include (in alphabetical order) Cytiva, G-CON Manufacturing, Germfree, IPM Technologies, KeyPlants, ModuleCo Pharma, NNE and Pharmadule.

The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:

The opinions and insights presented in the report were influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following industry stakeholders:

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews with experts in the area (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:

While the focus has been on forecasting the market over the coming 13 years, the report also provides our independent view on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

Question 1: What is modular manufacturing?

Answer: Modular facilities are prefabricated buildings that are built using multiple sections, often known as modules. To provide more context, modular constructs are designed, engineered and manufactured off-site, and later delivered to relevant project site for final installation. Further, integrated assemblies are joined together to create facilities of significant size, housing multiple functions and equipment.

Question 2: Which material is most widely used for the construction of modular facilities?

Answer: Steel and wood are the most commonly used materials for building pre-engineered builds. Of these, steel is usually employed to construct permanent buildings since they are built for use over longer periods of time. On the other hand, wood is generally more suitable for building relocatable constructs as the material is lightweight and hence, allows easy relocation.

Question 3: Which types of partnerships are being inked by modular facility providers?

Answer: Full facility construction agreements, service alliances and cleanroom construction agreements are the most common partnership models adopted by stakeholders engaged in the modular facilities domain.

Question 4: Which healthcare sector is rapidly employing modular facilities?

Answers: Currently, the pharmaceutical industry is leading the adoption of modular facilities in the healthcare sector. On the other hand, the modular facilities market for biotechnology industry is expected to grow at 11%, capturing a considerable market share in the foreseen future.

Question 5: How is the modular facilities market likely to grow in the future?

Answers: The global modular facilities market is anticipated to grow at a compound annualized growth rate of 10%, till 2035.

Question 6: Which region is leading the modular facilities market?

Answers: North America and Europe, combined, hold 70% share of the global modular facilities market. In the longer run, emerging regions, such as Asia, are likely to grow at faster pace.

CHAPTER OUTLINES

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS

5. MARKET LANDSCAPE: MODULAR CLEANROOM PROVIDERS

6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS

7. COMPANY PROFILES

8. PARTNERSHIPS AND COLLABORATIONS

9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY

10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY

11. COST-TIME OPTIMIZATION FRAMEWORK

12. MARKET FORECAST

2023-2035

13. PREVALENT AND EMERGING INDUSTRY TRENDS

14. FUTURE GROWTH OPPORTUNITIES

15. CONCLUSION

16. EXECUTIVE INSIGHTS

17. APPENDIX I: TABULATED DATA

18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기